Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis.
about
Pre-eclampsia part 1: current understanding of its pathophysiology.Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Endoglin in liver fibrogenesis: Bridging basic science and clinical practicePrediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis.In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth RestrictionMaternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic PathologiesIschemic placental syndrome--prediction and new disease monitoring.An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclThe use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Acute-phase proteins in prediction of preeclampsia in patients with abnormal midtrimester uterine Doppler velocimetry.Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile.
P2860
Q33416340-28A05716-E642-4E26-B843-824A110C0450Q33577443-553AFC5A-B2D1-4D84-B8FF-DD72DFBEC3B3Q33579089-02AD3B0B-60E3-433D-9E4C-595E50F54368Q33728841-513497AC-E05D-4B5C-999B-FCA49D19AF69Q34174363-33E34AB1-1699-45B3-A58B-5B6DF861C1E8Q34505704-E9699085-DBD3-4710-AB19-C27E551D3B54Q35362708-D5D71305-3105-4B4A-B299-475E9DFFD4C1Q36167912-992C5CAE-C2FE-4A96-8B57-3FBF081FA150Q37210911-841529DC-3AF3-4490-B51B-011878905B31Q38601408-7CAFB693-5B3E-4B6C-AB4B-4652ED2A3FA4Q47680120-1FA9F70E-BC55-44B5-A47D-52C353FA2BC7Q49312791-3547844A-FEDC-4051-9FCB-0E09AF7ACC70Q51696567-7CBC27D5-71DA-44F9-B836-00416B0CD61EQ55073231-EEEC9A20-6C35-4D37-B968-3F6A33A5E2A3
P2860
Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@en
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@nl
type
label
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@en
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@nl
prefLabel
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@en
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@nl
P2093
P2860
P1476
Angiogenic factors and acute-p ...... ents: a matched-pair analysis.
@en
P2093
Bernd Gerber
Dagmar-Ulrike Richter
Henrike Rohrmann
Michael O Glocker
Toralf Reimer
P2860
P304
P356
10.3109/14767058.2012.733747
P577
2012-10-19T00:00:00Z